COVID-19-Related Guidance Documents for Industry, FDA Staff, and Other Stakeholders | FDA

COVID-19-Related Guidance Documents for Industry, FDA Staff, and Other Stakeholders | FDA

Information for industry

April 30, 2020: SBIA Webinar: Conducting Clinical Trials During the COVID-19 Public Health Emergency - 1:00 - 1:45 p.m. ET (Note: This webinar is now full, but the recording will be available shortly after the webinar concludes.)  Reminder: FDA-ARGOS SARS-CoV-2 reference grade sequence data now available (April 1, 2020) The FDA is committed to providing timely recommendations, regulatory information, guidance, and technical assistance necessary to support rapid COVID-19 response efforts. FDA has issued 40 COVID-19-related guidances to date.

COVID-19-Related Guidance Documents